Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-27 @ 1:15 PM
Study NCT ID:
NCT01836432
Status:
TERMINATED
Last Update Posted:
2020-05-28
First Post:
2013-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Sponsor:
NewLink Genetics Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NLG0505
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None